SUPPORT-AF IV
SUPPORT-AF IV
批准号:
10685518
负责人:
Alok Kapoor
金额:
$63.39万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-06-30
关键词:
AdherenceAmericanAnticoagulantsAnticoagulationAppointmentAtrial FibrillationBehaviorBenefits and RisksCardiacCardiologyCaringCessation of lifeClient satisfactionCollaborationsCommunication ToolsDataDisparityDissemination and ImplementationEducational MaterialsEffectivenessElectronic Health RecordEligibility DeterminationEquilibriumEventFeedbackFire - disastersFloridaFutureGuidelinesHealth PersonnelHealth systemHemorrhageIndividualInformaticsInterviewIschemic StrokeKnowledgeLearningLeftLinkMeasurementMeasuresMethodsMinority GroupsOralOutcomePatient EducationPatientsPharmaceutical PreparationsPhasePopulationPopulation HeterogeneityPrevalencePreventionProviderRandomizedRegimenReportingResearchResourcesRisk FactorsSocietiesSpecialistStrokeStroke preventionTest ResultTestingUniversitiesVisitbehavioral studycare providersclinical decision supportcompliance behaviordesigndigitaldisabilityeffectiveness measurefallshealth disparityheart rhythmimplementation effortsimplementation scienceimplementation toolimprovedmedical specialtiesminority patientnovelpeer supportprematureprovider interventionsafety netsatisfactionshared decision makingstroke risksupport toolstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Six million Americans suffer from atrial fibrillation (AF), a heart rhythm abnormality that is increasing in
prevalence and is also a major risk factor for stroke. AF accounts for 15% of ischemic strokes, resulting in
permanent disability in 60% of cases and death in up to 20%. Oral anticoagulation (AC) is effective for AF-
related stroke prevention and the vast majority of AF patients have a guideline-directed indication for oral AC.
Despite this, only half of eligible AF patients receive treatment. This is particularly true among non-white AF
patients, in whom AC use is lower and stroke rates are higher. The proposed project, SUPPORT-AF IV:
Supporting Use of AC through Provider Prompting about Oral Anticoagulation Therapy for AF, will examine the
impact of a novel AC clinical decision support tool within the electronic health record (EHR) on AC prescribing
behaviors among healthcare providers from two distinct health systems who receive it. We will also examine
clinician engagement through provider interviews and detailed study of behaviors using electronic health
record access logs. Finally, we will refine the alert, develop a comprehensive dissemination plan, and create
an implementation toolkit to widen the use of the alert at other learning health systems nationally. Specific
Aims include: Aim 1: (alert enhancement) Enhance alert which will fire when eligible patients (those with AF
and elevated stroke risk not on AC) visit cardiology providers and PCPs; enhancements include links to
educational material, peership resources, and communication tools to use with patients not on AC. Aim 2:
(adherence: AC initiation and persistence) Measure adherence including AC initiation and AC persistence
(staying on AC for one year) in eligible patients (n=2632) of providers randomized to receive vs. not receive
alert ; repeat measurements in the subset of minority patients (n= 402). Aim 3: (mechanism of effect)
Measure association of digital crumbs with AC initiation and persistence; crumbs include alert specific actions
(opening smart set and linking out to patient educational materials, peership resources, and communication
tools), alert specific orders, other orders, and review of access log actions (review of various items - specialist
notes, cardiac testing results, or medication list). Aim 4: (provider and patient satisfaction) Interview
intervention providers (n=20) about satisfaction with alert and AC management; interview patients (n=25)
satisfaction with AC management received from intervention providers. Aim 5: (dissemination and
implementation) Refine alert, develop a comprehensive dissemination plan, and create an implementation
toolkit that captures all lessons learned from measuring effectiveness, mechanism of effect, and provider and
patient satisfaction.
We are applying for the R01 (PA-18-722) - Improving Patient Adherence to Treatment and Prevention
Regimens. Our research team brings together extensive expertise in AC care, informatics, implementation
science and health disparities that will guide us in the execution of the proposed aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Storytelling for Reducing Gap in AC Use in African Americans with Atrial Fibrillation
-
批准号:10667019
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2023
-
负责人:Alok Kapoor
-
依托单位:
SUPPORT-AF IV
-
批准号:10458767
-
项目类别:
-
资助金额:$63.27万
-
财政年份:2021
-
负责人:Alok Kapoor
-
依托单位:
SUPPORT-AF IV
-
批准号:10298960
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2021
-
负责人:Alok Kapoor
-
依托单位:
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs
-
批准号:9792333
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Alok Kapoor
-
依托单位:
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs
-
批准号:10165790
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Alok Kapoor
-
依托单位:
Older Adult Safety in Surgery (OASIS II)
-
批准号:8638620
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2014
-
负责人:Alok Kapoor
-
依托单位:
Older Adult Safety in Surgery (OASIS)
-
批准号:8184416
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2011
-
负责人:Alok Kapoor
-
依托单位:
Older Adult Safety in Surgery (OASIS)
-
批准号:8309029
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2011
-
负责人:Alok Kapoor
-
依托单位:
海外基金